Glaxosmithkline Plc Lyell Immunopharma, Inc. (LYEL) insider trading activity

LYEL Quotes by TradingView

GLAXOSMITHKLINE PLC Transaction History

Date Transaction Value Shares Traded Form
Jun 21 2021
BUY
Conversion of derivative security
-
30,253,189

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
> 10% Shareholder
SPRO
Spero Therapeutics, Inc. Healthcare
> 10% Shareholder
TBIO
Translate Bio, Inc. Healthcare
> 10% Shareholder
LQDA
Liquidia Technologies Inc
PRNB
Principia Biopharma Inc.
CCXI
ChemoCentryx, Inc.
TPTX
Turning Point Therapeutics, Inc.
Director
BCYC
BICYCLE THERAPEUTICS plc Healthcare
> 10% Shareholder
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
> 10% Shareholder
MORF
Morphic Holding, Inc. Healthcare
Director
FULC
Fulcrum Therapeutics, Inc. Healthcare
PGNY
Progyny, Inc. Healthcare
> 10% Shareholder
NKTX
Nkarta, Inc. Healthcare
Director
PAND
Pandion Therapeutics, Inc.
Director
DBTX
Decibel Therapeutics, Inc. Healthcare
Director
INVA
Innoviva, Inc. Healthcare
> 10% Shareholder
CVRX
CVRx, Inc. Healthcare
> 10% Shareholder
TBPH
Theravance Biopharma, Inc. Healthcare
WVE
Wave Life Sciences Ltd. Healthcare
> 10% Shareholder
GP

Glaxosmithkline PLC

> 10% Shareholder
Brentford Middlesex, X0

Track Institutional and Insider Activities on LYEL

Follow Lyell Immunopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYEL shares.

Notify only if

Insider Trading

Get notified when an Lyell Immunopharma, Inc. insider buys or sells LYEL shares.

Notify only if

News

Receive news related to Lyell Immunopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LYEL